MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-06-0017456
Meraggra Pharmaceutical Private Limited
Meraggra Pharmaceutical Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.76 Lakh
▼ 33% YoY
Net profit · FY 2025
₹25,775
Net margin 6.9%
EBITDA · FY 2025
₹44,132
EBITDA margin 11.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Meraggra Pharmaceutical Private Limited
Data last updated:
Meraggra Pharmaceutical Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24304MH2019PTC319738. Its GSTIN is 27AAMCM3709M1ZZ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Manish Dharmdas Ganvir and Laxman Gundaram Ramteke.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.64 Radhaniwas Apartment Suyognagar, Nagpur, Maharashtra, India – 440015.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.76 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹25,775 (net margin 6.9%) and EBITDA of ₹44,132 (EBITDA margin 11.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 40% over five years.
Meraggra Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-06-0017456). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24304MH2019PTC319738
Registration Number 319738
Incorporation Date 16 January 2019
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-06-0017456
Key People
Manish Dharmdas Ganvir Director Laxman Gundaram Ramteke Director Pravin Marotrao Gajbhiye Director Recognitions & Rankings of Meraggra Pharmaceutical
Contact details
Meraggra Pharmaceutical Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.64 Radhaniwas Apartment Suyognagar, Nagpur, Maharashtra, India – 440015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Meraggra Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Meraggra Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Meraggra Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Meraggra Pharmaceutical Private Limited, buy the company report.
Financials of Meraggra Pharmaceutical Private Limited
FY 2025 filings availableMeraggra Pharmaceutical Private Limited reported revenue of ₹3.76 Lakh (down 33% YoY) for FY 2025.
Revenue · FY 2025
₹3.76 Lakh ▼ 33%
Net profit · FY 2025
₹25,775 margin 6.9%
EBITDA · FY 2025
₹44,132 margin 11.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 33%
3 years · compounded
▲ 5%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▼ 28%
3 years · compounded
▲ 43%
5 years · compounded
▲ 34%
Revenue fell 33% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 40%. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44,132 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25,775 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.7% | ||||
| Net Profit Margin | 6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meraggra Pharmaceutical Private Limited, buy the company report.
Board of directors of Meraggra Pharmaceutical Private Limited
Meraggra Pharmaceutical has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Dharmdas Ganvir | Director | 19 Jul 2019 | 7 Years 3 Months | Current |
| Laxman Gundaram Ramteke | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Pravin Marotrao Gajbhiye | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Madhukar Hiraman Rangari | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Premdas Shankar Meshram | Director | 05 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Meraggra Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Religence Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2025) | 7.0% | Bhavnagar, Gujarat, India | |||
| Vision Gupta Engineering Private Limited | ₹3.8 Lakh (FY 2024) | 104.0% | Kolkata, West Bengal, India | |||
| Neesi Pharmaceuticals Private Limited | ₹3.78 Lakh (FY 2023) | 39.0% | Indore, Madhya Pradesh, India | |||
| Gauri India Chemtech Private Limited | ₹3.78 Lakh (FY 2025) | -85.0% | Haridwar, Uttarakhand, India | |||
| Smush Enterprises (OPC) Private Limited | ₹3.77 Lakh (FY 2025) | 15.0% | Delhi, India | |||
| Meraggra Pharmaceutical Private Limitedthis company | ₹3.76 Lakh (FY 2025) | ₹25,775 | 6.9% | -33.0% | Nagpur, Maharashtra, India | |
| Astragenesis Healthcare Private Limited | ₹3.75 Lakh (FY 2022) | -73.0% | Delhi, India | |||
| CNM Nanotechnologies Private Limited | ₹3.75 Lakh (FY 2024) | 24.0% | Vadodara, Gujarat, India | |||
| Soulmate Life Science Private Limited | ₹3.74 Lakh (FY 2025) | Sihora, Madhya Pradesh, India | ||||
| Safex Medical Products Private Limited | ₹3.73 Lakh (FY 2019) | -60.0% | Kolkata, West Bengal, India | |||
| Vetatech Pharmaceuticals Private Limited | ₹3.73 Lakh (FY 2023) | Ahmednagar, Maharashtra, India |
To see the full peer comparison of Meraggra Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Meraggra Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meraggra Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Meraggra Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCM3709M1ZZ | Maharashtra | Active | 28 Jan 2019 |
To see the full GST registrations and return filing status of Meraggra Pharmaceutical Private Limited, buy the company report.
Recent activity
Meraggra Pharmaceutical Private Limited has 6 board changes on record since 2019: 5 appointments and 1 cessation. The latest: Premdas Shankar Meshram ceased to be Additional Director on 31 Dec 2020.
AGM
Meraggra Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Meraggra Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Ceased
Premdas Shankar Meshram ceased to be Additional Director.
Appointed
Manish Dharmdas Ganvir was appointed as Director.
Appointed
Premdas Shankar Meshram was appointed as Director.
Appointed
Laxman Gundaram Ramteke was appointed as Director.
Appointed
Madhukar Hiraman Rangari was appointed as Director.
Appointed
Pravin Marotrao Gajbhiye was appointed as Director.
Incorporation
16 Jan 2019
Meraggra Pharmaceutical Private Limited was registered on 16 Jan 2019 with Roc Nagpur & aged 7 years 9 months as per MCA records.
Frequently asked questions
Meraggra Pharmaceutical is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2019 (7+ years old) and is registered under CIN U24304MH2019PTC319738.
Meraggra Pharmaceutical has 5 current directors:
- Manish Dharmdas Ganvir - Director
- Laxman Gundaram Ramteke - Director
- Pravin Marotrao Gajbhiye - Director
- Madhukar Hiraman Rangari - Director
- Premdas Shankar Meshram - Director
The latest financial statements of Meraggra Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Meraggra Pharmaceutical is 27AAMCM3709M1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Meraggra Pharmaceutical is U24304MH2019PTC319738. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meraggra Pharmaceutical was incorporated on 16 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Meraggra Pharmaceutical by revenue are Religence Pharmaceuticals Private Limited, Vision Gupta Engineering Private Limited, Neesi Pharmaceuticals Private Limited, Gauri India Chemtech Private Limited, Smush Enterprises (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Premdas Shankar Meshram ceased to be Additional Director on 31 Dec 2020. Manish Dharmdas Ganvir was appointed as Director on 19 Jul 2019. Premdas Shankar Meshram was appointed as Director on 05 Feb 2019. Meraggra Pharmaceutical has 6 board changes on record in total.
Yes, Meraggra Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-06-0017456).
The registered office of Meraggra Pharmaceutical is at Plot No.64 Radhaniwas Apartment Suyognagar, Nagpur, Maharashtra, India – 440015.
Meraggra Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.